Literature DB >> 758174

Iron absorption in the thalassemia syndromes and its inhibition by tea.

P A de Alarcon, M E Donovan, G B Forbes, S A Landaw, J A Stockman.   

Abstract

To determine the hemoglobin concentration at which iron absorption is minimal, five subjects with thalassemia major and one with thalassemia intermedia underwent a series of iron-absorption studies. The effect of tea as an inhibitor of non-heme iron absorption was also tested. Iron absorption increased as the hemoglobin concentration decreased, although iron absorption was much higher at any given hemoglobin level in the subject with thalassemia intermedia. In the subjects with thalassemia major, iron absorption averaged 10 per cent at hemoglobin concentrations between 9 and 10 and 2.7 per cent between 11 and 13 g per deciliter. The percentage of iron absorbed could be accurately predicted from the nucleated red-cell count (r = 0.91, P less than 0.001). Tea produced a 41 to 95 per cent inhibition of iron absorption. Since patients with thalassemia intermedia may absorb a large percentage of dietary iron, inhibitors of iron absorption, such as tea, may be useful in their management.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758174     DOI: 10.1056/NEJM197901043000102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  14 in total

1.  Body iron status associated with tea consumption.

Authors:  C S Farkas
Journal:  Can Med Assoc J       Date:  1979-09-22       Impact factor: 8.262

2.  Zinc bioavailability and tea consumption. Studies in healthy humans consuming self-selected and laboratory-controlled diets.

Authors:  V Ganji; C V Kies
Journal:  Plant Foods Hum Nutr       Date:  1994-10       Impact factor: 3.921

3.  Management of thalassaemia major.

Authors:  B Modell; M Petrou
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

4.  Haemoglobin levels and blood requirement in thalassaemia.

Authors:  V Gabutti; A Piga; P Nicola; C Vullo; L Capra; A Di Palma; G Masera; S Terzoli; R Mauri
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

Review 5.  Anaemia and iron deficiency in athletes. Practical recommendations for treatment.

Authors:  J C Chatard; I Mujika; C Guy; J R Lacour
Journal:  Sports Med       Date:  1999-04       Impact factor: 11.136

6.  Inadequate dietary intake in patients with thalassemia.

Authors:  Ellen B Fung; Yan Xu; Felicia Trachtenberg; Isaac Odame; Janet L Kwiatkowski; Ellis J Neufeld; Alexis A Thompson; Jeanne Boudreaux; Charles T Quinn; Elliott P Vichinsky
Journal:  J Acad Nutr Diet       Date:  2012-05-01       Impact factor: 4.910

Review 7.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis.

Authors:  J P Kaltwasser; E Werner; K Schalk; C Hansen; R Gottschalk; C Seidl
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

9.  Polyphenols in brown algaeFucus vesiculosus andAscophyllum nodosum: Chemical defenses against the marine herbivorous snail,Littorina littorea.

Authors:  J A Geiselman; O J McConnell
Journal:  J Chem Ecol       Date:  1981-11       Impact factor: 2.626

Review 10.  Mechanisms of heme iron absorption: current questions and controversies.

Authors:  Adrian-R West; Phillip-S Oates
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.